- vaccine: BNT162b2
  dosage: 1.0
  infection: ''
  num_ref_name: 27
  num_fold: 4093
  S: 3167
  I: 742
  R: 184
  median_fold: 2.0
  percent: 4.0
  priority: 1
- vaccine: BNT162b2
  dosage: 1.0
  infection: infected
  num_ref_name: 24
  num_fold: 1273
  S: 891
  I: 346
  R: 36
  median_fold: 3.0
  percent: 1.2
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 180
  num_fold: 21128
  S: 14668
  I: 4738
  R: 1722
  median_fold: 2.9
  percent: 21.0
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 45
  num_fold: 2909
  S: 1836
  I: 960
  R: 113
  median_fold: 3.1
  percent: 2.8
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 70
  num_fold: 5954
  S: 3443
  I: 2186
  R: 325
  median_fold: 4.0
  percent: 5.8
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: infected
  num_ref_name: 12
  num_fold: 679
  S: 540
  I: 118
  R: 21
  median_fold: 2.0
  percent: 0.66
  priority: 1
- vaccine: mRNA-1273
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 155
  S: 131
  I: 24
  R: 0
  median_fold: 1.5
  percent: 0.15
  priority: 2
- vaccine: mRNA-1273
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 14
  S: 7
  I: 4
  R: 3
  median_fold: 5.3
  percent: 0.014
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 67
  num_fold: 9216
  S: 6211
  I: 2507
  R: 498
  median_fold: 3.9
  percent: 9.0
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: infected
  num_ref_name: 9
  num_fold: 393
  S: 268
  I: 101
  R: 24
  median_fold: 3.1
  percent: 0.38
  priority: 2
- vaccine: mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 19
  num_fold: 4080
  S: 2919
  I: 1119
  R: 42
  median_fold: 4.3
  percent: 4.0
  priority: 2
- vaccine: mRNA-1273
  dosage: 3.0
  infection: infected
  num_ref_name: 4
  num_fold: 347
  S: 226
  I: 117
  R: 4
  median_fold: 2.3
  percent: 0.34
  priority: 2
- vaccine: AZD1222
  dosage: 1.0
  infection: ''
  num_ref_name: 9
  num_fold: 1346
  S: 515
  I: 327
  R: 504
  median_fold: 11.0
  percent: 1.3
  priority: 3
- vaccine: AZD1222
  dosage: 1.0
  infection: infected
  num_ref_name: 3
  num_fold: 43
  S: 41
  I: 2
  R: 0
  median_fold: 2.1
  percent: 0.042
  priority: 3
- vaccine: AZD1222
  dosage: 2.0
  infection: ''
  num_ref_name: 39
  num_fold: 2747
  S: 1545
  I: 701
  R: 501
  median_fold: 4.2
  percent: 2.7
  priority: 3
- vaccine: AZD1222
  dosage: 2.0
  infection: infected
  num_ref_name: 12
  num_fold: 528
  S: 468
  I: 37
  R: 23
  median_fold: 1.5
  percent: 0.51
  priority: 3
- vaccine: AZD1222
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 471
  S: 225
  I: 246
  R: 0
  median_fold: 5.8
  percent: 0.46
  priority: 3
- vaccine: BBIBP-CorV
  dosage: 2.0
  infection: ''
  num_ref_name: 10
  num_fold: 2518
  S: 1384
  I: 799
  R: 335
  median_fold: 4.1
  percent: 2.4
  priority: 5
- vaccine: BBIBP-CorV
  dosage: 3.0
  infection: ''
  num_ref_name: 6
  num_fold: 609
  S: 170
  I: 438
  R: 1
  median_fold: 9.4
  percent: 0.59
  priority: 5
- vaccine: BBV152
  dosage: 2.0
  infection: ''
  num_ref_name: 7
  num_fold: 477
  S: 449
  I: 7
  R: 21
  median_fold: 1.4
  percent: 0.46
  priority: 6
- vaccine: BBV152
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 170
  S: 151
  I: 0
  R: 19
  median_fold: 2.4
  percent: 0.17
  priority: 6
- vaccine: CoronaVac
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 134
  S: 134
  I: 0
  R: 0
  median_fold: 4.3
  percent: 0.13
  priority: 7
- vaccine: CoronaVac
  dosage: 1.0
  infection: infected
  num_ref_name: 3
  num_fold: 390
  S: 242
  I: 148
  R: 0
  median_fold: 3.3
  percent: 0.38
  priority: 7
- vaccine: CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 19
  num_fold: 2050
  S: 1440
  I: 590
  R: 20
  median_fold: 2.8
  percent: 2.0
  priority: 7
- vaccine: CoronaVac
  dosage: 2.0
  infection: infected
  num_ref_name: 7
  num_fold: 250
  S: 136
  I: 74
  R: 40
  median_fold: 4.7
  percent: 0.24
  priority: 7
- vaccine: CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 12
  num_fold: 1546
  S: 602
  I: 944
  R: 0
  median_fold: 5.2
  percent: 1.5
  priority: 7
- vaccine: CoronaVac
  dosage: 3.0
  infection: infected
  num_ref_name: 3
  num_fold: 938
  S: 559
  I: 379
  R: 0
  median_fold: 3.6
  percent: 0.91
  priority: 7
- vaccine: NVX-CoV2373
  dosage: 2.0
  infection: ''
  num_ref_name: 4
  num_fold: 253
  S: 110
  I: 72
  R: 71
  median_fold: 7.3
  percent: 0.25
  priority: 8
- vaccine: ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 6
  num_fold: 611
  S: 172
  I: 399
  R: 40
  median_fold: 8.1
  percent: 0.59
  priority: 10
- vaccine: Sputnik V
  dosage: 2.0
  infection: ''
  num_ref_name: 8
  num_fold: 568
  S: 396
  I: 130
  R: 42
  median_fold: 4.0
  percent: 0.55
  priority: 11
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: ''
  num_ref_name: 22
  num_fold: 1490
  S: 1079
  I: 343
  R: 68
  median_fold: 2.9
  percent: 1.4
  priority: 12
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: infected
  num_ref_name: 8
  num_fold: 198
  S: 141
  I: 48
  R: 9
  median_fold: 2.6
  percent: 0.19
  priority: 12
- vaccine: Ad26.COV2.S
  dosage: 2.0
  infection: ''
  num_ref_name: 7
  num_fold: 502
  S: 289
  I: 197
  R: 16
  median_fold: 4.6
  percent: 0.49
  priority: 12
- vaccine: KCONVAC
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 251
  S: 241
  I: 10
  R: 0
  median_fold: 1.2
  percent: 0.24
  priority: 21
- vaccine: Convidecia
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 215
  S: 215
  I: 0
  R: 0
  median_fold: 1.4
  percent: 0.21
  priority: 22
- vaccine: BNT162b2 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 327
  S: 86
  I: 238
  R: 3
  median_fold: 7.7
  percent: 0.32
  priority: 29
- vaccine: BNT162b2 + mRNA-1273
  dosage: 3.0
  infection: infected
  num_ref_name: 2
  num_fold: 149
  S: 124
  I: 17
  R: 8
  median_fold: 1.4
  percent: 0.14
  priority: 29
- vaccine: mRNA-1273 + mRNA-1273.211
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 4882
  S: 4850
  I: 32
  R: 0
  median_fold: 2.3
  percent: 4.7
  priority: 32
- vaccine: AZD1222 + Sputnik V
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 76
  S: 0
  I: 76
  R: 0
  median_fold: 9.5
  percent: 0.074
  priority: 35
- vaccine: CoronaVac or BBIBP-CorV
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 588
  S: 541
  I: 47
  R: 0
  median_fold: 4.2
  percent: 0.57
  priority: 36
- vaccine: BBIBP-CorV + ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 252
  S: 52
  I: 182
  R: 18
  median_fold: 7.8
  percent: 0.24
  priority: 37
- vaccine: Ad26.COV2.S + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 270
  S: 135
  I: 135
  R: 0
  median_fold: 5.4
  percent: 0.26
  priority: 38
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 9
  num_fold: 649
  S: 372
  I: 271
  R: 6
  median_fold: 4.7
  percent: 0.63
  priority: 39
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: infected
  num_ref_name: 2
  num_fold: 92
  S: 68
  I: 24
  R: 0
  median_fold: 2.0
  percent: 0.089
  priority: 39
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 225
  S: 98
  I: 107
  R: 20
  median_fold: 7.5
  percent: 0.22
  priority: 41
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 6
  S: 6
  I: 0
  R: 0
  median_fold: 0.65
  percent: 0.0058
  priority: 41
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 580
  S: 425
  I: 155
  R: 0
  median_fold: 2.6
  percent: 0.56
  priority: 41
- vaccine: AZD1222 + CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 209
  S: 120
  I: 29
  R: 60
  median_fold: 3.3
  percent: 0.2
  priority: 42
- vaccine: AZD1222 + BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 89
  S: 89
  I: 0
  R: 0
  median_fold: 2.6
  percent: 0.087
  priority: 43
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 12
  num_fold: 1792
  S: 511
  I: 457
  R: 824
  median_fold: 12.0
  percent: 1.7
  priority: 46
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 12
  S: 6
  I: 5
  R: 1
  median_fold: 4.9
  percent: 0.012
  priority: 46
- vaccine: AZD1222 + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 8
  num_fold: 1115
  S: 459
  I: 410
  R: 246
  median_fold: 7.9
  percent: 1.1
  priority: 46
- vaccine: AZD1222 + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 177
  S: 166
  I: 11
  R: 0
  median_fold: 2.5
  percent: 0.17
  priority: 47
- vaccine: AZD1222 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 680
  S: 560
  I: 120
  R: 0
  median_fold: 1.8
  percent: 0.66
  priority: 47
- vaccine: AZD1222 + mRNA
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 60
  S: 0
  I: 52
  R: 8
  median_fold: 9.4
  percent: 0.058
  priority: 52
- vaccine: Unknown vaccine
  dosage: 2.0
  infection: infected
  num_ref_name: 9
  num_fold: 817
  S: 642
  I: 114
  R: 61
  median_fold: 2.2
  percent: 0.79
  priority: 1000
- vaccine: Unknown vaccine
  dosage: 3.0
  infection: infected
  num_ref_name: 5
  num_fold: 487
  S: 400
  I: 79
  R: 8
  median_fold: 2.6
  percent: 0.47
  priority: 1000
